Skip to main content

A child sits with his mother

Two families reflect on their malaria vaccine journey

Catching up with the first children to receive the RTS,S malaria vaccine in Malawi, one year later.

PATH welcomes landmark financing agreement for GSK's malaria vaccine

PATH congratulates Gavi, GSK, and MedAccess for joining forces to help ensure an ongoing supply of the first malaria vaccine, RTS,S/AS01_E.

GSK, PATH, and Bharat Biotech sign product transfer agreement to help ensure long-term supply of RTS,S/AS01E malaria vaccine

Bharat Biotech will produce the antigen for RTS,S/AS01 following technology transfer.

We’re ready to beat malaria. Are you?

Put your knowledge to the test with a three-question quiz. Ready to begin?

Home

Latest

PATH applauds WHO recommendation for broader use of first malaria vaccine

PATH welcomes remarkable results from clinical trial combining RTS,S/AS01 malaria vaccine with Seasonal Malaria Chemoprevention

Frequently Asked Questions (FAQs): RTS,S/AS01 for seasonal use

PATH welcomes landmark financing agreement for GSK’s malaria vaccine

GSK, PATH, and Bharat Biotech sign product transfer agreement to help ensure long-term supply of RTS,S/AS01E malaria vaccine

Frequently Asked Questions (FAQs): Product Transfer for the RTS,S/AS01 Malaria Vaccine

Milestone study identifies immune markers that may help predict success of vaccination with RTS,S/AS01 malaria vaccine

PATH receives new five-year contract from USAID for malaria vaccine research and development

A child sits with his mother

Two families reflect on their malaria vaccine journey

PATH continues exciting partnership with the GHIT Fund to develop a next-generation malaria vaccine

Characterization of two in vivo challenge models to measure functional activity of monoclonal antibodies to Plasmodium falciparum circumsporozoite protein

Journal article

RTS,S Malaria Vaccine: 2019 Partnership Award Honoree

Twitter @MalariaVaccine

RT @MoetiTshidi: Great news! I welcome SAGE's recommendation on widespread use of the RTS,S #MalariaVaccine. This offers a glimmer… https://t.co/OFvvVSWioh

7 Oct 2021

History in the making! Today @WHO recommends widespread use of the first #MalariaVaccine, RTS,S, among children at… https://t.co/Gwv89KpGmk

6 Oct 2021

RT @nytimes: Breaking News: The WHO approved the first ever malaria vaccine, which could save tens of thousands of children in s… https://t.co/1YPqvmKrdd

6 Oct 2021

RT @WHOAFRO: Today’s @WHO recommendation for wider use of the RTS,S #MalariaVaccine was made possible through evidence generated… https://t.co/QOPgaYIpAU

6 Oct 2021

Study shows that providing a fractional booster dose of the RTS,S/AS01 #vaccine to #malaria naive adults can extend… https://t.co/H3xNViKXVX

5 Oct 2021

RT @PAlonsoMalaria: Malaria: a problem to be solved and a time to be bold | Nature Medicine ⁦@WHO⁩ ⁦@MoetiTshidi⁩ ⁦@rajpanjabi⁩ ⁦… https://t.co/oEJJ0f8Wx2

17 Sep 2021

RT @prasannaj77: Interested in human immunology of malaria and clinical trials? The Jagannathan Lab at Stanford is recruiting post-… https://t.co/OT6eHpQM89

16 Sep 2021

RT @BillGates: This news is not surprising to many of us who work in global health. But there are things the world can do to help… https://t.co/N9rLUTTfaH

13 Sep 2021

RT @JHMRImalaria: #CallingAllScientists Please Save the Date, Nov 12 for the Future of Malaria Research symposium. And submit abstrac… https://t.co/ZYTbJfnGwh

10 Sep 2021

RT @GlobalFund: Working together @GlobalFund partnership has saved 44 MILLION lives since 2002. But for the first time in Global Fu… https://t.co/5PfU5KhrGJ

9 Sep 2021

RT @NatureMedicine: ⭐ Research Highlight: A monoclonal antibody can prevent #malaria, according to early clinical data published in… https://t.co/otuc2skfoc

7 Sep 2021

New article in @Nature_NPJ shows that certain antibodies are associated with protection against #malaria infection: https://t.co/USpCambqrI

3 Sep 2021